FDA Approves Treatment for CD55-Deficient Protein-Losing Enteropathy
The treatment is the first of its kind to be FDA-approved to treat CHAPLE disease.
Source: pharmacytimes.com
Page 40 - Boxed Warning News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Boxed Warning Today - Breaking & Trending Today
Merck Announces WELIREG® (belzutifan) Phase 3 LITESPARK-005 Trial Met Primary Endpoint of Progressio
First positive Phase 3 results for WELIREG from LITESPARK-005 showed statistically significant improvements in PFS versus everolimus in these patientsRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from LITESPARK-005,...
Source: pharmiweb.com
FDA approves first treatment for CHAPLE disease
INDIANA - The FDA has approved Veopoz (pozelimab-bbfg) injection, a complement inhibitor, for the treatment of adult and pediatric patients 1 year of age and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease. Veopoz is the first FDA-approved treatment for C ...
Source: wbiw.com
Altruix Approved to Dispense Brixadi® for Moderate to Severe Opioid Use Disorder
/PRNewswire/ -- Altruix, a leading provider of behavioral health pharmacy solutions, announced today that it has been selected as a limited distribution...
Source: prnewswire.com
Sohonos Approved for Fibrodysplasia Ossificans Progressiva
The FDA has approved Sohonos™ (palovarotene) for patients with fibrodysplasia ossificans progressiva.
Source: empr.com